Fatty Liver Treatment Market Forecast 2024-2033

Spread the love

Overview and Scope
Fatty liver disease is a condition in which fat builds up in the liver, causing various symptoms and complications. Fatty liver treatment refers to the multiple strategies, interventions, and actions to address and manage fatty liver disease.

Sizing and Forecast
The fatty liver treatment market size has grown strongly in recent years. It will grow from $22.17 billion in 2023 to $23.58 billion in 2024 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to obesity epidemic, sedentary lifestyles, unhealthy diets, limited treatment options, awareness campaigns.

The fatty liver treatment market size is expected to see strong growth in the next few years. It will grow to $30.11 billion in 2028 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to increased disease prevalence, rising healthcare expenditure, growing diabetes and metabolic syndrome, innovation in therapeutics. Major trends in the forecast period include precision medicine approaches, lifestyle modification programs, targeted therapies for nash, non-invasive monitoring tools, technological advancements.

To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/fatty-liver-treatment-global-market-report

Segmentation & Regional Insights
The fatty liver treatment market covered in this report is segmented –

1) By Treatment Type: Anti-Rejection Drugs Or Immunosuppressants, Chemotherapy Drugs, Targeted Therapy, Vaccines, Anti-Viral Drugs
2) By Disease Type: Hepatitis, Liver Cancer, Non-Alcoholic Fatty Liver Disease, Other Diseases
3) By End User: Hospitals, Ambulatory Surgery Centers, Other End Users

North America was the largest region in the fatty liver treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the fatty liver treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample_request?id=12581&type=smp

Major Driver Impacting Market Growth
The increase in alcohol consumption is expected to propel the growth of the fatty liver treatment market going forward. Alcohol consumption refers to consuming beverages containing alcohol, a psychoactive substance with depressant effects on the central nervous system. Alcohol consumption can worsen fatty liver disease and lead to more severe liver conditions, including alcoholic fatty liver disease (AFLD) and alcoholic hepatitis. For instance, in December 2022, according to a report published by Kirin Holdings Company Limited, a Japan-based beverages company, about 185.60 million kiloliters of beer were consumed worldwide in 2021, a rise of 4.0% from 2020. Therefore, the increase in alcohol consumption is driving the growth of the fatty liver treatment market.

Key Industry Players

Major companies operating in the fatty liver treatment market report are Pfizer Inc., Johnson & Johnson Services Inc., Hoffmann La Roche Ltd., AstraZeneca PLC, Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., The Bristol-Myers Squibb Company, GlaxoSmithKline PLC, Mitsubishi Chemical Holdings, Takeda Pharmaceutical Company Limited, Gilead Sciences Inc., Novo Nordisk A/S, Eisai Co. Ltd., Zydus Lifesciences Limited, Glenmark Pharmaceuticals Limited, GW Pharmaceuticals Limited, Retrophin Inc., Alnylam Pharmaceuticals Inc., Intercept Pharmaceuticals Inc., AbbKine Scientific Co. Ltd., Daewoong Co. Ltd., Madrigal Pharmaceuticals Inc., Orchid Chemicals & Pharmaceuticals Limited, Genfit, NGM Biopharmaceuticals Inc., Cardax Inc., Conatus Pharmaceuticals Inc., Limerick Biopharma Inc.

The fatty liver treatment market report table of contents includes:

1. Executive Summary
2. Fatty Liver Treatment Market Characteristics
3. Fatty Liver Treatment Market Trends And Strategies
4. Fatty Liver Treatment Market – Macro Economic Scenario
5. Global Fatty Liver Treatment Market Size and Growth
.
.
.
31. Fatty Liver Treatment Market Other Major And Innovative Companies
32. Global Fatty Liver Treatment Market Competitive Benchmarking
33. Global Fatty Liver Treatment Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Fatty Liver Treatment Market
35. Fatty Liver Treatment Market Future Outlook and Potential Analysis
36.Appendix

Explore the trending research reports from TBRC:

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293

Email: [email protected]

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model


Spread the love

About Top PR News

TopPRnews Leads Drives Search Engine Visibility For Your Press Release Content. Our Global Network Reaches Important Contacts, Media Partners And Websites And Journalists. Happy Postings! If You Have Any Queries Please Contact Official Mail At [[email protected]}

View all posts by Top PR News →